pCas2C Citations (1)

Originally described in: CRISPR interference as a titratable, trans-acting regulatory tool for metabolic engineering in the cyanobacterium Synechococcus sp. strain PCC 7002.
Gordon GC, Korosh TC, Cameron JC, Markley AL, Begemann MB, Pfleger BF Metab Eng. 2016 Jul 29. pii: S1096-7176(16)30062-3. doi: 10.1016/j.ymben.2016.07.007. PubMed Journal

---

Articles Citing pCas2C

Articles
High-Density Guide RNA Tiling and Machine Learning for Designing CRISPR Interference in Synechococcus sp. PCC 7002. Dallo T, Krishnakumar R, Kolker SD, Ruffing AM. ACS Synth Biol. 2023 Apr 21;12(4):1175-1186. doi: 10.1021/acssynbio.2c00653. Epub 2023 Mar 9. PubMed

If you have published an article using this material, please email us at to have your article added to this page.